Cargando...
Bevacizumab (Avastin)
Bevacizumab is a humanized monoclonal antibody that was the first FDA approved therapy designed to inhibit angiogenesis. This paper will review the mechanism of action and clinical role of this antiangiogenic agent.
Guardado en:
| Publicado en: | AJNR Am J Neuroradiol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society of Neuroradiology
2010
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7964163/ https://ncbi.nlm.nih.gov/pubmed/20037132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A1987 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|